Allied Minds , an innovative U.S. science and technology development and commercialization company, today announced that its subsidiary company, SciFluor Life Sciences, has raised $30 million. Proceeds will be used to accelerate its two lead compounds - one a topical treatment for retinal diseases and the second a treatment for neurological diseases - while expanding its drug discovery and commercialization pipeline.